SOAP NOTE

User Generated

Gbaljvmneq

Health Medical

Wilkes University

Description

SUBJECTIVE:

Chief Complaint:

New patient Telepsychiatry audio/video

History Of Present Illness:

20 year old male presented with

Medical History:

Patient Denies any Negative Cardiac Hx, Negative Respiratory Hx, Negative Seizures Hx, Negative Head Trauma Hx, and Negative Family Cardiac History. Psychiatric/Mental Health History: Patient denies any previous suicidal attempts. Patient reports positive previous psychiatric hospitalization/admissions after being held in Jail. Patient was brought to Hospital (July 20) for detox by his girlfriend and mother in which he stayed for approximately 2 days to flush drug out of the system. Was not discharged with psyhatric medications as per patient and girlfriend.

Family History:

Maternal: Positive for Psychiatric (Bipolar Disorder), Negative for Substance, and Negative for Alcohol. Paternal: Negative for Psychiatric, Negative for Substance, and Positive for Alcohol. *(Died when patient was 9 year old)*

Social History:

Marital Status: Single Children: Denies Living Situation: Single Occupation: Non Employed (Recently fired from HomeDepot and charged with Grand Theft) / Adult Student (Full-time) Tallahassee state college for sports medicine. Current Income: Public Assistance scholarship money and looking for a job. Substance Abuse History: Yes Drug type: Edible THC gummies ( 3x times the potency) Patient is socially appropriate for age. Legal Status: Positive for Grand Theft after stealing from Homedepot July 31 and Criminal Trespassing on Hotel grounds July 19. Functional Status: Denies physical limitations. HIV-STD prevention: In a monogamous relationship. Safe sex education provided to reduce transmission. Seat belt safety: Discussed to wear always. Skin Cancer Prevention: Avoids the sun, tanning beds. Smoking cessation: Educated on prevention. Patient advised to reduce exposure to second hand smoke whenever possible.

Smoking Status: Never Smoked

Review of System:

Constitutional: Negative for activity change, appetite change and fatigue.

Cardiovascular: Negative for chest pain, palpitations and leg swelling.

Psychiatric: Positive for agitation, Positive for behavioral problems and negative confusion at present time. Negative for passive suicidal thoughts, intent or plan at present time. Negative for active suicidal thoughts, intent or plan at present time.

OBJECTIVE:

Vital Signs:

Height: 73.00 in

Weight: 163.00 lbs

BMI: 21.50

Resp. Rate: 18

Physical Exam:

Constitutional: Oriented to person, place, and time. Appears well-developed and well-nourished. No distress.

Neurological/Psychiatric: General/Orientation: Awake, alert and oriented x3. No acute distress. Appearance, general attitude and behavior: Appears stated age. Combed hair. Fair hygiene. Casually dressed. Hyperactive, talkative, and disorganized. Fair eye contact. Abnormal Movements/Gait: Psychomotor agitation noted. Fidgeting and inability to sit still. Stable gait. Characteristic and/or quality of speech: Pressured speech especially when speaking about his hallucinations while under the Edible THC. Mood and Affect: Irritability with low frustration tolerance. labile. Thought Process: Flight of ideas and easily distracted. Thought Content: Ruminations about his hallucinations while under the Edible THC. Perceptual Disturbances: Paranoid features "I feel like someone is following me" and "I always have to look over my shoulder". "It has gotten worst after the THC edible". Suicidal ideations/Homicidal ideations: Denied active suicidal/homicidal ideations, intent or plan at present time. Memory: Grossly intact. Attention/Concentration: Poor/Poor Insight and Judgement: Poor/Poor Medication Side Effects: Patient denied. None observed.

ASSESSMENT:

Diagnosis:

ICD-10 Codes:

1)F3162; Bipolar disorder, current episode mixed, moderate

2)F19151; Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with hallucinations

3)Z630; Problems in relationship with spouse or partner

4)Z9149; Other personal history of psychological trauma, not elsewhere classified

5)F5105; Insomnia due to other mental disorder

6)F1210; Cannabis abuse, uncomplicated

7)Z653; Problems related to other legal circumstances

PLAN:

Procedures:

1) 99205; E&M of a new patient, mod to high severity (60min)

2) 90838; Psychotherapy (at least 53 minutes) with E&M code

Procedure Notes:

I reviewed patients GAD7: & PHQ9: Mood Questionnaire: Pos Anxiety/Mood Disorders psychotherapy: Provided modalities of cognitive behavioral therapy and interpersonal psychotherapy while helping to express and clarify thoughts, feelings, and concerns. Discussed at length achievable Goals including but not limited to: Improving problem solving/coping/insight, increase distress tolerance, improve interpersonal skills, reduced symptom induced distress, maintaining a consistent routine, schedule, and anticipating stressful situations. Creating a plan and allowing extra time to work with your plan. Practicing stress management or self-calming techniques Diaphragmatic Breathing that you have learned from your mental health care provider. Exercise regularly and spend time outdoors. Eat a healthy diet that includes plenty of vegetables, fruits, whole grains, low-fat dairy products, and lean protein. Do not eat a lot of foods that are high in fat, added sugar, or salt (sodium). Drinking plenty of water. Avoiding alcohol and illicit substances which can increase anxiety. Avoid caffeine and certain over-the-counter cold medicines as these may make you feel worse. Understanding that you are likely to have setbacks. Accept this and be kind to yourself as you persist in taking better care of yourself. Recognize and accept your accomplishments, even if you judge them as small. Spending time with people who care about you and keeping all follow-up visits for optimal mental health benefit and wellbeing. We discussed working towards these Goals to achieve improvement and eventual resolution in symptoms if attainable depending on clinical presentation and medical condition. A total of 70 minutes of supportive psychotherapy was spent along with coordination of care. Instructions provided regarding diagnosis, recommendations, and treatment plan. Questions were welcomed and answered.

Orders:

1) 005009; CBC With Differential/Platelet (lab order)

2) 058867; CMP12+8AC (lab order)

3) 000620; Thyroid Panel With TSH (lab order)

4) 081950; Vitamin D, 25-Hydroxy (lab order)

5) 000810; Vitamin B12 and Folate (lab order)

6) 700841; Drug Screen 10 w/Conf, Serum (lab order)

Medications:

lamoTRIgine 25 MG Oral Tablet Disintegrating; Place 1 tablet orally daily; Qty: 14; Refills: 0

OLANZapine 10 MG Oral Tablet Disintegrating; Place 1 tablet orally at bedtime; Qty: 30; Refills: 0

Care Plan:

Patient Education: Antipsychotics: These agents include the “typical” or first-generation antipsychotics and the “atypical” or second-generation antipsychotics. First-generation antipsychotics include chlorpromazine, fluphenazine, haloperidol, and perphenazine. ---Although these drugs are effective, their long-term use can result in a muscle movement disorder known as tardive dyskinesia, which consists of fine tremor, muscle spasms, and rigidity. **** Second-generation antipsychotics include aripiprazole, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone. ---These medications, though less likely to cause movement disorders, have a unique set of side effects, including weight gain, high cholesterol, and an increased risk of diabetes. ---Anyone taking either type of antipsychotic should be monitored routinely for side effects. ---Antipsychotics should not be stopped abruptly but should always be tapered off slowly or replaced with another drug according to a medical provider direction. Antipsychotics often improve many of the symptoms of schizophrenia within a few weeks of therapy. ---It is critical that antipsychotics be continued even after symptoms have improved in order to avoid relapse. ---If one antipsychotic does not relieve symptoms, it is possible another agent will work. ---Patients should always tell their medical provider and pharmacist about any other prescription drugs, OTC products, vitamins, or supplements they are taking to avoid serious drug interactions. Patient verbilized understanding and accepts risks and complications.

-Start on Olanzapine 10 mg PO daily at HS.

Care Plan Continuation:

Patient Education: Mood Stabilizers (Lamictal) A serious, life-threatening skin rash (also known as Stevens–Johnson Syndrome) may occur with the use of lamotrigine. **Contact your health care provider immediately, call 911, and/or go to local ER if you have any of the following: a skin rash, blistering or peeling of your skin, hives, shortness of breath, or painful sores in your mouth or around your eyes.*** --Studies have found that individuals who take antiepileptic medications including lamotrigine have suicidal thoughts or behaviors up to twice as often than individuals who take placebo (inactive medication). These thoughts or behaviors occurred in approximately 1 in 500 patients taking the antiepileptic class of medications. If you experience any thoughts or impulses to hurt yourself, you should contact your doctor immediately, call 911, and or go to your local ER. --Aseptic meningitis, a serious inflammation of the protective membrane that covers the brain and spinal cord has been identified as a very rare but serious side effect of lamotrigine. Patient instructed to contact your health care provider immediately, call 911, and/or go to local ER if you experience headache, fever, nausea, vomiting, stiff neck, rash, unusual sensitivity to light, muscle pains, chills, confusion, or drowsiness while taking lamotrigine. -Start on Lamictal 25 mg PO QD for two weeks then 50 mg for two weeks.

Care Plan Continuation:

Insomnia: Discussed with patient methods to ensure adequate sleep hygiene:-Including keeping regular sleeping and waking times -spending less than 8 hours in bed maintaining nutrition and exercise -avoiding sleep altering substances such as caffeine and alcohol. -Start on Olanzapine 10 mg PO daily at HS.

Patient Instructions/FU:

Patient instructed to call 911 or visit local ER for any acute life threatening symptoms including but not limited to: chest pain, palpitations (abnormal heart beat), low blood pressure (<115/70), elevated blood pressure (>160/100), shortness of breath, difficulty breathing, fever above 101.5, seizures, muscle weakness or rigidity, abnormal skin rash (SJS), numbness of extremity, difficulty speaking, falls, and uncontrollable bleeding. All questions answered to patient satisfaction. Follow up: 2-4 weeks, 1 months if chronic condition such as but not limited to Depression, Anxiety, and schizophrenia. Labs: TSH; B12; Folate; CBC, CMP to rule out medical cause for psychiatric symptoms. ***Patient instructed to take all medications as prescribed and Follow up with Therapist as scheduled. ***Follow up with appropriate medical providers as needed. ***Abstain from all illicit drugs, alcohol or mind altering substances. ***Risks, benefits, alternative to treatment and side effects of medication discussed with patient who verbalized understanding and agreement with this treatment plan. ***Safety plan discussed with patient: Tell a friend;Tell a family member; call the office; call 911 or go to nearest ER if you develop thoughts of harming self or others or develop symptoms of psychosis; call crisis line at 988 Suicide & Crisis Lifeline https://988lifeline.org/.

Unformatted Attachment Preview

SOAP Notes Each student will complete three (3) SOAP notes. SOAP Notes are to be posted to the DB in a copy & paste fashion for ease of reading and reference. Please do not attach a link to the document These Soap Notes will stimulate discussion, questions, and critique by peers and instructors. Soap Notes are to be posted in weeks 1, 5, and 9 by Sunday at 11:59. Discussion including at least one meaningful response to at least one of your peers’ Soap Notes should occur by Wednesday at 11:59pm EST in weeks 2, 6, and 10. A meaningful response is one that demonstrates critical thought. Refer to the Carlat, Robinson and Sadock, Sadock & Ruiz texts for assistance. Posts that are perfunctory or only minimally meeting all grading criteria do not necessarily qualify as “excellent” which would yield full points (100). This is true for both the initial post and the response post. One response post is considered to minimally meet criteria. Refer to the SOAP Note Grading Rubric. Discussion responses and responses to other required student posts should be a minimum of 150 words, scholarly written, APA formatted, and referenced. A minimum of 2 references are required (other than the course textbook). Refer to the Grading Rubric for Online Discussions for grading criteria. Purpose: To record information from the patient, family members, friends, other data bases, other professionals (nurses, physicians, labs, X-ray, Etc.), in order to accurately ascertain the information which you need to know about the patient and their disease process(es), so that you can make an accurate diagnosis and provide advice on the most appropriate treatment. The written record also provides a means of communication between you and your professional colleagues. It should be written in a manner which allows the reader to “see” what you observed, performed, discussed and plan to do for and with the patient. SOAP notes are generally done as a follow up after an initial H & P (Psychiatric evaluation) has been done. Criteria A. S Subjective data appropriately documented. Chief complaint, interval history and review of symptoms. B. O Objective data appropriately documented. Vitals, review of testing and lab work, MSE. C. A Assessment appropriately documented. Review diagnoses and current treatment plan for accuracy and relevance. D. P Plan to include cost-effective and evidence-based treatment. Include labs to order, meds and dosage, counseling and referrals, teaching plan, follow up (add to what was done if you would do something other than your preceptor- in italics). E. Include neurobiology of disorder(s). (Include genetics, neurotransmitters, neuroanatomical changes, current theories of causation, cultural factors). F. Rationale for each part of management plan (labs; meds: why this med, what is neurochemistry action of med, side effects to monitor, expected benefits, contraindications; counseling-goals, rationale for this type of therapy, expected benefits, teaching, referrals, follow-up). Include references from at least 3 sources including one article from refereed journal. Syllabus NSG 536: 2021- 2022 SOAP NOTE FORMAT/EXAMPLE: (Note: This example is not exhaustive and yours must include additional data such as elaboration of rationale, neurobiology, or other information important for an academic exercise but not necessarily appropriate for a clinical document in practice) PSYCHIATRIC PROGRESS NOTE (SOAP) NAME: Doe, John DATE: 05/1/2021 Subjective: CC: “I was in the hospital”. John is seen today as a status post hospitalization visit. He was hospitalized at from 04/26/21 to 04/30/21. He was apparently admitted for increased agitation and aggression, making threats toward his mother and his niece, with whom he had been living. John states that he does not believe he had been taking his medications correctly, but he also acknowledges that there was increased stressors at the time of hospitalization with his mother and his niece. It is not clear how long John had been living with his mother and niece. The last time he was seen at this clinic was in March of 2010 and he was a resident of Bellvue Personal Care Home. He now resides back at Bellvue Personal Care Home after discharge. John was stabilized and then discharged on his previous medication regimen. He was given a diagnosis of Chronic Paranoid Schizophrenia. However, John appears to have a significant mood component and has been diagnosed with Schizoaffective Disorder, which will continue to be his working diagnosis. John also states that he has quit smoking. He has not smoked in six days and plans to continue abstinence. His sleep, appetite, and weight remain stable. Objective MSE: The patient is casually dressed and groomed. He looks very good today. He has good skin color. He is alert. He appears to be in good spirits. He makes good eye contact. He is calm and cooperative. Speech is regular in rate and tone, relevant, with some latency of response. Thoughts appear to be goal directed. He relates his mood as “good”. Affect is restricted. He denies any mood lability or instability, nor is there any noted. There is no evidence of any delusional thinking. There is no evidence of any perceptual disturbances. There is no evidence any suicidal or homicidal ideation and he denies same. He is alert and oriented X three. Assessment: Schizoaffective Disorder, Nicotine Use Disorder, Panic Disorder with Agoraphobia, Mild Intellectual Disability, Peptic Ulcer Disease; Gastritis; Hyperlipidemia; Obesity; Type II Diabetes; Early Diabetic Retinopathy; Disc Disease; Abnormal Tongue Movements; History of Thyroid Disease; Recent hospitalization and Housing issues Current Medications: a. Geodon 80 mg, po bid b. Clonazepam 1 mg po qid c. Fluoxetine 40 mg one po q day d. Lithium Carbonate 300 mg, three tablets po q h.s. Plan: Continue with John’s current medication regimen. He has been doing well since discharge. He relates that he has been getting along with everyone at Bellevue. He has not had any further problems with anger, aggression, or agitation. During his previous residence at Bellevue, he was somewhat disgruntled and was seeking different housing; however, it appears that once than happened and he moved in with his mother his stressors increased and he destabilized. He is working with his Syllabus NSG 536: 2021- 2022 caseworker to find alternative housing that would be appropriate. He will also continue in outpatient therapy with. John verbalizes understanding of, and agrees with, this treatment plan. He is encouraged to contact this office with further questions or concerns. He will be return to the office in four weeks for reevaluation, or sooner, as needed. *Include neurobiology of disorder(s). (Include genetics, neurotransmitters, neuroanatomical changes, current theories of causation, cultural factors). *Rationale for each part of management plan (labs; meds: why this med, what is neurochemistry action of med, side effects to monitor, expected benefits, contraindications; counseling-goals, rationale for this type of therapy, expected benefits, teaching, referrals, follow-up). Include references from at least 3 sources including one article from refereed journal. Signature/credentials Syllabus NSG 536: 2021- 2022 Syllabus NSG 536: 2021- 2022
Purchase answer to see full attachment
User generated content is uploaded by users for the purposes of learning and should be used following Studypool's honor code & terms of service.

Explanation & Answer

Attached.

Psychiatric Progress Note (Soap) - Outline
I.

Subjective
A. CC

B. History of presenting illness (HPI)
C. Review of symptoms
II.

Objective
A. Vitals
B. Review of testing
C. Lab work
D. Mental status exam (MSE)
1) Appearance:
2) Behavior:
3) Mood and affect:
4) Thought process.
5) Thought content.
6) Perception:
7) Memory:
8) Orientation:
9) Concentration and attention:
10) Speech:
11) Insight and judgment:

III.

Assessment
A. Bipolar disorder, current episode mixed, moderate (F3162)
B. Other psychoactive substance abuse with psychoactive substance-induced psychotic
disorder with hallucinations (F19151)

C. Cannabis abuse, uncomplicated (F1210)
D. Current medications
IV.

Plan
A. Lab works and rationales
1) CBC with differential/platelet
2) Thyroid panel with TSH
3) Drug screen 10w/confirmation
B. Medication management, expected benefits, and side effects
1) Lamotrigine 25mg oral tablets:
2) Olanzapine 10mg oral tablets:

C. Psychotherapy and rationale
1) Cognitive behavioral therapy (CBT):
2) Supportive psychotherapy:

D. Teaching Plan
1) Medication adherence:
2) Substance abuse effects:
3) Lifestyle modifications:

E. Follow-up and Referral:
1) Referral to psychotherapist:
2) Follow-up appointment:

F. Neurobiology
1) Bipolar disorder usually develops when there is dysregulation in various
neurotransmitters.
2) The neurotransmitters associated with the development of this disorder

include glutamate, serotonin, and dopamine.


1

Psychiatric Progress Note (Soap)

Name
Institution
Course
Instructor
Date

2
Psychiatric Progress Note (Soap)
Name: J.M.

Date: 30/08/2024
Subjective

CC: "I am experiencing psychotic symptoms, mood instability, and legal issues."
History of Presenting Illness (HPI)
J.M., a 20-year-old Caucasian male patient, presents to a psychiatric clinic via
telepsychiatry audiovisual, complaining of various psychiatric symptoms and legal issues. The
patient reports that these issues have occurred for a prolonged period that he is unable to specify,
and he keeps on experiencing exacerbations whenever he takes high-potency THC edibles. The
patient claims that these issues significantly affect his emotions and mental condition, leading to
poor cognition and behavior. During the telepsychiatry audiovisual consultation, the patient
reports experiencing acute exacerbations of psychiatric symptoms since he had recently taken
use of THC edibles and claims to have an underlying mood instability for a prolonged period.
The patient describes his psychiatric symptoms to be characterized by mood instability,
irritability, agitation, hyperactivity, and paranoia. He adds that he has a hallucination history
whenever he uses THC edibles, followed by paranoia.
He also claims that his condition is also associated with labile mood and low frustration
tolerance. According to this patient, the mentioned psychiatric symptoms are aggravated by the
recent loss of employment, lack of a structured routine, legal stressors, and use of THC edibles.
Although he does not report any current relieving factors, he claims that he had been hospitalized
with the help of his mother and girlfriend for two days for detoxification, after which he was
arrested. After arrest, the patient was charged with criminal...

Similar Content

Related Tags